Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
Stomach Ulcer

About this trial
This is an interventional treatment trial for Stomach Ulcer focused on measuring gastric stress ulcer, Prevacid, Prostaglandin
Eligibility Criteria
Inclusion Criteria: Patients in ICU with documented gastric stress ulcer by endoscopic examination, including patients with H. Pylori infection; Patients have no known ulcer within 8 weeks prior to be admitted to ICU; Patients not on any PPI for 4 weeks prior to the study; Patients or family be consented for the study. Exclusion Criteria: Patients have gastric ulcer within 8 weeks prior to be admitted to ICU; Patients have gastric cancer confirmed by pathology; Patients on one of the PPIs already; Patients on any of the Non-steroidal Antiinflammatory Drugs.
Sites / Locations
- Emory University School of Medicine
Arms of the Study
Arm 1
Experimental
Prevacid
Effect of Prevacid at 8 weeks; EGD(esophagogastroduodenal endoscopy) at day 1 & EGD at 8 weeks